• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record

    6/25/25 8:55:00 AM ET
    $GKOS
    $ICE
    $JBS
    Medical/Dental Instruments
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $GKOS alert in real time by email

    NEW YORK, June 25, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Kristen Scholer delivers the pre-market update on June 25th

    • Equities are little changed Wednesday morning after jumping by more than 1% on Tuesday. The DOW gained over 500 points while the S&P 500 sits just shy of a record high.
    • Driving those gains were easing tensions in the Middle East, resulting in crude oil prices falling by approximately 5% during Tuesday's session. President Trump announced a ceasefire agreement on Monday night.
    • Fed Chair Powell reiterated the Central Bank's wait-and-see approach to cutting interest rates in a testimony before the House Financial Services Committee on Tuesday. The Fed last cut rates in December.

    Opening Bell

    JBS N.V. (NYSE:JBS) celebrates its recent listing

    Closing Bell

    Glaukos Corporation (NYSE:GKOS) celebrates the 10th anniversary of its IPO

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--sp-500-trades-within-1-of-record-302490894.html

    SOURCE New York Stock Exchange

    Get the next $GKOS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GKOS
    $ICE
    $JBS

    CompanyDatePrice TargetRatingAnalyst
    JBS N.V.
    $JBS
    6/26/2025$20.00Outperform
    BMO Capital Markets
    JBS N.V.
    $JBS
    6/18/2025$21.00Buy
    BofA Securities
    Glaukos Corporation
    $GKOS
    5/1/2025$86.00Overweight → Equal Weight
    Wells Fargo
    Glaukos Corporation
    $GKOS
    2/19/2025$140.00 → $200.00Neutral → Outperform
    Mizuho
    Glaukos Corporation
    $GKOS
    12/11/2024$132.00 → $162.00Neutral → Buy
    Citigroup
    Glaukos Corporation
    $GKOS
    12/6/2024$182.00Buy
    UBS
    Glaukos Corporation
    $GKOS
    12/2/2024$120.00Equal-Weight → Underweight
    Morgan Stanley
    Intercontinental Exchange Inc.
    $ICE
    10/14/2024$185.00Strong Buy → Outperform
    Raymond James
    More analyst ratings

    $GKOS
    $ICE
    $JBS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Advisory: Pre-Market Update + ESPN celebrates streaming service launch

    NEW YORK, Aug. 21, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 21st Stocks are lower this morning as the S&P 500 looks to end a four-day losing streak amid recent pressure on the tech sector.The Federal Reserve remains in focus for Wall Street as the Central Bank released the latest minutes from July's meeting on Wednesday. This shed more light on policymaker's concerns about inflationNYSE-listed Disney's sports media giant ESPN will ring

    8/21/25 8:55:00 AM ET
    $CMI
    $ICE
    Industrial Machinery/Components
    Industrials
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market Update + NYSE Texas to celebrate launch at AT&T Stadium

    NEW YORK, Aug. 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 20th Stocks are fractionally lower following a mixed session on Tuesday that saw the DOW hit an intraday high before pulling back. NYSE-listed Home Depot led the gains after it maintained its full-year forecast.The Federal Reserve will be in focus today ahead of its Economic Policy Symposium later this week. The central bank will release the latest fed minutes from July's meeti

    8/20/25 8:55:00 AM ET
    $BBAI
    $ICE
    $T
    Computer Software: Prepackaged Software
    Technology
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market Update + Retail Earnings Kick Off

    NEW YORK, Aug. 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 19th Stocks are mixed after Monday saw little change to the major averages. The retail sector will make headlines today as NYSE-listed Home Depot released earnings ahead of market open.Investors will be keeping a close eye on the numbers to gauge how the consumer is faring amid inflation and trade policy uncertainty.Investors are bracing for what the Fed says later this week at

    8/19/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on JBS SA with a new price target

    BMO Capital Markets initiated coverage of JBS SA with a rating of Outperform and set a new price target of $20.00

    6/26/25 8:10:45 AM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    BofA Securities initiated coverage on JBS SA with a new price target

    BofA Securities initiated coverage of JBS SA with a rating of Buy and set a new price target of $21.00

    6/18/25 11:37:52 AM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    Glaukos downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Glaukos from Overweight to Equal Weight and set a new price target of $86.00

    5/1/25 7:44:23 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    SEC Filings

    View All

    $GKOS
    $ICE
    $JBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Intercontinental Exchange Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Intercontinental Exchange, Inc. (0001571949) (Filer)

    8/20/25 4:30:56 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form S-8 filed by Glaukos Corporation

    S-8 - GLAUKOS Corp (0001192448) (Filer)

    8/20/25 4:15:43 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by JBS N.V.

    S-8 - JBS N.V. (0001791942) (Filer)

    8/15/25 4:45:58 PM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    Chief Executive Officer Sprecher Jeffrey C exercised 66,575 shares at a strike of $57.31 and sold $39,653,199 worth of shares (216,575 units at $183.09) (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    8/14/25 4:30:17 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Director Bowen Sharon sold $146,890 worth of shares (794 units at $185.00), decreasing direct ownership by 5% to 14,206 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    7/29/25 4:32:15 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Director Bowen Sharon sold $145,724 worth of shares (795 units at $183.30), decreasing direct ownership by 5% to 15,000 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    7/2/25 4:30:36 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    Financials

    Live finance-specific insights

    View All

    Intercontinental Exchange Approves Third Quarter Dividend of $0.48 per Share

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, announced today a $0.48 per share dividend for the third quarter of 2025, which is up 7% from the $0.45 per share dividend paid in the third quarter of 2024. The cash dividend is payable on September 30, 2025 to stockholders of record as of September 16, 2025. The ex-dividend date is September 16, 2025. About Intercontinental Exchange Intercontinental Exchange, Inc. (NYSE:ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-

    7/31/25 7:35:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange Reports Strong Second Quarter 2025

    Intercontinental Exchange (NYSE:ICE):  Record 2Q25 net revenues of $2.5 billion, +10% y/y                 2Q25 GAAP diluted earnings per share (EPS) of $1.48, +35% y/y                 2Q25 adj. diluted EPS of $1.81, +19% y/y                 Record 2Q25 operating income of $1.3 billion, +22% y/y; record adj. operating income of $1.6 billion, +14% y/y                 2Q25 operating margin of 51%; adj. operating margin of 61%                 Through June 30, 2025, returned over $1 billion to stockholders, including $496 million in share repurchases     Jeffrey C. Sprecher, ICE Chair & Chief Executive Officer, said, "We are p

    7/31/25 7:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Glaukos Announces Second Quarter 2025 Financial Results

    Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2025. Key highlights include: Record net sales of $124.1 million in Q2 2025 increased 30% year-over-year on a reported basis and 29% year-over-year on a constant currency basis. Glaucoma record net sales of $103.5 million in Q2 2025 increased 36% year-over-year. U.S. Glaucoma record net sales of $72.3 million in Q2 2025 increased 45% year-over-year. Gross margin of approximately 78% and non-GAAP gross margin of approxima

    7/30/25 4:05:00 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Leadership Updates

    Live Leadership Updates

    View All

    Mizuho Americas Joins ICE Clear Credit as Clearing Member

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that Mizuho Americas through its security-based swap dealer Mizuho Capital Markets LLC, part of Mizuho Financial Group (NYSE:MFG), has become a clearing member at ICE Clear Credit, the leading global clearinghouse for credit default swaps. "Mizuho Americas is excited to join ICE Clear Credit to enhance our product offering and approach to capital and risk management delivering efficiencies across our CDS portfolios," said Natalya Rasmussen, Chief Operating Officer, Fixed Income Division, Mizuho Americas. "The opportunity to centrally clear products is an important step forward for

    8/6/25 9:00:00 AM ET
    $ICE
    $MFG
    Investment Bankers/Brokers/Service
    Finance
    Major Banks

    The New York Stock Exchange Appoints Bryan Daniel to Lead NYSE Texas and Announces Location of NYSE Texas Headquarters

    The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced the appointment of Bryan Daniel as President, NYSE Texas and establishment of the headquarters of NYSE Texas. In this role, Bryan will report directly to Lynn Martin, President, NYSE Group. Daniel brings extensive experience in public policy, most recently serving as the Chairman of the Texas Workforce Commission (TWC) where he promoted the growth of Texas' employers and workforce through collaboration with TWC's education partners, local officials, and industry leaders. Prior to joining TWC, Daniel served on Texas Governor Greg Abbott's seni

    8/4/25 8:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    New CFO Appointment Signals Next Phase of Growth and Innovation at ReSource Pro

    Veteran finance and technology executive brings multi-industry leadership and a history of driving impactful change to ReSource Pro. ReSource Pro, a leading provider of strategic operations solutions for the insurance industry, today announced the appointment of Eugene ("Gene") Hugh as Chief Financial Officer. He will lead the company's Accounting, Financial Planning & Analysis, Tax, Treasury, Legal, and Mergers & Acquisitions functions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250708592777/en/Gene Hugh, CFO of ReSource Pro "With Gene's strong financial expertise and operational leadership, we're confident he will be a k

    7/8/25 8:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Glaukos Corporation

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    11/14/24 1:21:45 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Glaukos Corporation (Amendment)

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    2/14/24 3:55:55 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Glaukos Corporation (Amendment)

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    2/13/24 5:41:34 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care